INTRODUCTION
Morbid obesity and its associated comorbidities are important public health problems worldwide. Over the past several decades, the prevalence of obesity has been dramatically increasing in all populations. According to the updated data of the World Health Organization in 2017, the number of overweight and obese adults globally was ＞1.9 billion (39%) and ＞650 million (13%), respectively, in 2016, and the worldwide prevalence of obesity nearly tripled between 1975 and 2016 [1] . In Korea, the prevalence of obesity with a body mass index (BMI) of ≥30 kg/m 2 has rapidly increased, with the prevalence in 2013 (4.2%) being almost double that in 2002 (2.5%) [2] . As the obese population increases in number, the incidence of type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, cardiovascular disease (CVD), stroke, reproductive disorders, cancer, and other obesity-related comorbidities is also increasing, and the management of these conditions has enormous social costs [3] .
Bariatric surgery has emerged as the best option for treating obesity and its related comorbidities, showing better effects than nonsurgical therapy such as diet and lifestyle modification or pharmaceutical therapy [4, 5] .
Many studies have already shown that bariatric surgery has significant benefits against T2DM, hypertension, and dyslipidemia, which are risk factors for CVD, thus suggesting that bariatric surgery may also improve CVD risk [6] [7] [8] [9] .
The Framingham General Cardiovascular Risk Score Heart Association (ACC/AHA), are generally used to quantitatively assess the 10-year CVD risk [10, 11] . Several studies have addressed the efficacy of bariatric surgery in reducing the CVD risk based on either the FRS or PCE, or both [12] [13] [14] [15] . However, some investigators demonstrated that FRS and PCE can overestimate the risk in populations in Europe and Asia including Korea [16] [17] [18] [19] [20] [21] . To adjust these interpopulation differences, the Korean Heart Study introduced the Korean Risk Prediction Model (KRPM), which showed better discrimination and calibration than FRS and PCE in the Korean population [20, 22, 23] . To our knowledge, there has been no study on Asian populations about the effect of bariatric surgery on the CVD risk based on these prediction models.
In addition, studies on which kind of bariatric surgery would be more beneficial in improving the CVD score are rare. Several studies reported that laparoscopic Roux-en Y gastric bypass (LRYGB), laparoscopic sleeve gastrectomy (LSG), and laparoscopic adjustable gastric banding reduced the CVD risk score; however, most of them were noncomparative studies [12, [24] [25] [26] and only few studies directly compared LSG and LRYGB [13] [14] [15] 27] .
The aim of this study was to quantitatively evaluate the effects of bariatric surgery on CVD risk reduction in Korean obese patients by using three different CVD risk prediction models (FRS, PCE, and KRPM), and to investigate which procedure between LRYGB and LSG is the better option for CVD risk reduction based on differences in CVD risk scores.
MATERIALS AND METHODS
We retrospectively reviewed the prospectively collected www.framinghamheartstudy.org/fhs-risk-functions/card iovascular-disease-10-year-risk/ and https://professional.
heart.org/professional/GuidelinesStatements/Prevention Guidelines/UCM_457698_ASCVD-Risk-Calculator.jsp.
The KRPM score was calculated using Excel spreadsheets with the coefficients provided by the Korean Heart Study [20] . The heart/vascular age was also calculated using the FRS and previously mentioned variables. This calculation provides the estimated heart or vascular age of the patient in comparison with the real chronologic age. The maximum heart age that this tool can calculate is 86 years [11] . The ideal cardiovascular risk is obtained by calculating the PCE score with the mean age of the patient, BMI ≤25 kg/m 2 , and no comorbidities [10] . Remission of T2DM was defined as normal measurements of glucose metabolism (glycated hemoglobin ＜6.5%, fasting blood glucose ＜126 mg/dL) in the absence of antidiabetic medications.
Remission of hypertension was defined as a blood pressure of ＜140/90 mmHg without antihypertensive medications [28] . scores and heart/vascular age were improved significantly after LRYGB; however, SBP and the status of T2DM were not meaningfully changed after surgery. Table 4 shows the changes in parameters related to CVD risk between baseline and 1 year after LSG. The BMI, PCE score, KRPM score, and heart/vascular age were significantly decreased after LSG, and total cholesterol and HDL were marginally improved; however, SBP, hypertension and T2DM status, and FRS showed no significant differences between before and after surgery. Table 5 compares the parameters related to CVD risk between LRYGB and LSG at 1-year follow-up. There was no significant difference in all parameters related to CVD risk scores between the two groups.
Statistical analysis

DISCUSSION
To the best of our knowledge, this paper has significance in that it is the first study to be conducted on an Asian This study demonstrated that bariatric surgery reduces the CVD risk, as significant improvement of all CVD risk scores were observed after surgery. This result is concordant with that of other studies that used FRS or PCE [13] [14] [15] .
However, the FRS or PCE scores at baseline and after surgery in this study seemed to be lower than those in previous studies. The FRS at baseline and 1 year after surgery in our study showed a mean value of 10.3% and 4.1% respectively, whereas the FRS was 26.6% and 16.7%, respectively, in one study [15] and 34.5% and 15.5%, respectively, in another study [13] . With respect to PCE, our data (5.2% and 2.7% at baseline and 1 year after surgery, respectively) were lower than those of a previous study (11.6 and 7.8, respectively) [14] . We speculated on the reasons for these large differences between our study and other studies. First, there were differences in the factors involved in the calculation of scores among the studies.
When compared with the study population of Blanco et al. was reported [26] . Second, there were differences in the calculation methods of the risk scores. We used the lipid-based FRS for the prediction of CVD; however, other studies used the BMI-based FRS, which could produce higher estimates than the lipid-based FRS in obese patients [13, 15] . However, a similar relative risk reduction was observed between this study (39.6% in FRS and 48.5% in PCE) and other studies (37.2%, 37.5%, 55.1% in FRS [13] [14] [15] and 32.8% in PCE [14] ), although the absolute risk reduction in this study was lower than that in other studies.
Moreover, the heart/vascular age was also reduced by an amount similar to that reported in other studies (absolute age reduction: 11.3 years in this study; 10.8 years in Blanco et al. [14] and 8.4 years in Gutierrez-Blanco et al. [15] ). This means that bariatric surgery significantly reduces the CVD risk regardless of racial disparity.
The CVD risk varies as a function of diet, lifestyle, and ethnic origin. The KRPM score was estimated lower than the FRS at baseline and 1 year after surgery in this study.
Some investigators reported that the FRS has a tendency of overestimating the risk of CVD when applied to the Korean population, in which the CVD incidence is low; therefore, this makes it difficult to apply the risk prediction models as they were developed [18, 29] . Jung et al. [20] reported that the 2.67 at baseline, 3.55±2.17 at 1 year after surgery; data not shown). In the preoperative evaluation for selecting candidates for bariatric surgery, the application of PCE in male patients has the risk of overestimating the CVD risk.
Thus, KRPM can be considered a possible alternative for the risk calculation.
We observed no significant difference in the CVD risk scores between LRYGB and LSG in Korean patients. Studies comparing the CVD risk score between two surgical procedures are scarce [13] [14] [15] . All studies were retrospective studies that concluded that both procedures have good effects in terms of CVD risk reduction, with no significant difference. Two randomized controlled trials published in 2018 compared the long-term outcomes over a 5-year follow-up period in patients who underwent LSG and LRYGB [8, 9] . Although these studies did not directly compare the CVD risk scores, the CVD risk scores can be indirectly inferred by comparing the factors that determine the scores. In the study by Peterli et al. [8] , there was no significant difference in total cholesterol, HDL, and remission of hypertension and T2DM between the LSG and LRYGB groups. On the other hand, in the study by Salminen et al. [9] , there was no difference in total cholesterol, HDL, and remission of T2DM between the LSG and LRYGB groups, but 51% of the patients in the LRYGB group discontinued hypertension medications and showed significantly better results than those in the LSG group (29%). These results suggest that the CVD risk score in the LRYGB group may be better than that in the LSG group.
However, this is only an indirect comparison. To obtain more evidence, well-designed studies with a CVD score as the primary endpoint should be conducted.
This study has several limitations associated with its retrospective nature, lack of randomization, small sample size, and short-term follow-up period. There is also a chance of selection bias because only patients with complete data at follow-up were included. Despite these shortcomings, this is, to our best knowledge, the first study on an Asian population to compare and analyze LRYGB and LSG in terms of cardiovascular risk outcomes based on various CVD risk score models. Continued efforts to revise the risk prediction models by using newer and ethnic-specific cohorts will provide more insight in the future.
CONCLUSION
LRYGB and LSG can equally decrease the CVD risk in the Korean population based on FRS, PCE, and KRPM.
